throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.,
`
`Petitioner,
`
`v.
`
`TELEFLEX INNOVATIONS S.À.R.L.,
`
`Patent Owner.
`
`Case IPR2020-01341
`Case IPR2020-01343
`U.S. Patent No. 8,142,413
`U.S. Patent No. RE 46,116
`
`PETITIONER’S MOTION FOR ADDITIONAL DISCOVERY:
`MOTION FOR LEAVE TO SUBPOENA NON-PARTY WITNESSES
`(FILED WITH BOARD AUTHORIZATION)
`
`REDACTED
`
`

`

`Pursuant to 35 U.S.C. § 316(a)(5) and 37 C.F.R. § 42.51(b)(2), Petitioner
`
`moves for leave to serve subpoenas for testimony on three non-party witnesses:
`
`Jim Kauphusman, a former VSI engineer; Katie Mytty, a former VSI technician;
`
`and Jeff Welch, a named inventor on the patents-in-suit and former VSI employee.
`
`As the Board knows, conception and reduction to practice is a critical,
`
`dispositive issue in these proceedings.1 The conception and reduction to practice
`
`record will dictate whether one of Petitioner’s references, Itou, is prior art. The
`
`limited record in these proceedings shows that Kauphusman, Mytty, and Welch
`
`have unique, first-hand knowledge of whether VSI reduced the claimed inventions
`
`to practice via assembly and testing of GuideLiner RX prototypes. Yet we have not
`
`heard from these individuals. By all accounts, they are the ones who would have
`
`led and performed the engineering and prototype work required to reduce to
`
`practice. Petitioner seeks their testimony because it has evidence that these
`
`
`1 To the extent Patent Owner argues that the Board already decided conception and
`
`reduction to practice in the related set of IPRs, Petitioner submits that the patents at
`
`issue here recite method claim and, thus, change the character of the reduction-to-
`
`practice analysis. Patent Owner will need to show that VSI performed the claimed
`
`processes, making the details of the testing and, as a result, the individuals who
`
`purportedly performed that testing, all the more significant.
`
`1
`
`REDACTED
`
`

`

`individuals did not perform RX prototype work during the relevant period, before
`
`Itou. Kauphusman’s and Mytty’s laboratory notebooks show that they worked on
`
`only OTW (prior art)—not RX (patented)—prototypes during the relevant period.
`
`Welch’s notebook does not mention GuideLiner until years after the Itou reference.
`
`Root tries to offer an explanation for the conspicuous discrepancy in the
`
`record. See Ex-2118 ¶ 94 (arguing that the Kauphusman and Mytty notebooks
`
`“show VSI’s testing of GuideLiner OTW in preparation for submitting our
`
`application to the FDA for regulatory clearance, not for purposes of confirming the
`
`device would work”). But the record contains no evidence that VSI sought
`
`regulatory clearance for or commercialized its OTW device. A more plausible
`
`explanation for the absence of RX notebook entries (based not on inventor say-so
`
`but on the evidentiary record) is that the key engineering witnesses did not
`
`assemble and test RX prototypes until after Itou. Petitioner moves the Board for
`
`leave to get that explanation into the record. This case turns on whether VSI
`
`performed the requisite engineering work; the requested testimony is crucial.
`
`The Garmin factors favor granting additional discovery and determining,
`
`from the key sources, whether Patent Owner can swear behind Itou.
`
`I.
`
`Legal Standard
`
`“Under the Leahy-Smith America Invents Act, discovery is available for . . .
`
`‘what is otherwise necessary in the interest of justice.’” Garmin Int’l, Inc. v.
`
`2
`
`REDACTED
`
`

`

`Cuozzo Speed Techs. LLC, IPR2021-00001, Paper 26 at 5 (PTAB Mar. 5, 2013)
`
`(precedential) (quoting 35 U.S.C. § 316(a)(5)); see also 37 C.F.R. § 42.51(b)(2)
`
`(“The moving party must show that such additional discovery is in the interests of
`
`justice . . . .”).
`
`The Board’s precedential Garmin decision identifies five factors “important”
`
`to deciding whether to allow additional discovery: (1) more than a possibility and
`
`mere allegation; (2) litigation positions and underlying basis; (3) ability to generate
`
`equivalent information by other means; (4) easily understandable instructions; and
`
`(5) requests not overly burdensome to answer. Garmin, Paper 26 at 6.
`
`II.
`
`
`
`First Garmin factor: The record demonstrates more than a possibility or
`mere allegation that Kauphusman, Mytty, and Welch will provide
`useful testimony that will allow Petitioner to rebut Patent Owner’s
`reduction-to-practice arguments.
`
`Under the first Garmin factor, “[t]he party requesting discovery should
`
`already be in possession of evidence tending to show beyond speculation that in
`
`fact something useful will be uncovered.” Garmin, Paper 26 at 6. “Useful” means
`
`“favorable in substantive value to a contention of the party moving for discovery.”
`
`Id. at 7. Here, laboratory notebooks and other VSI engineering documents,
`
`declarations, and deposition testimony more than suggest that Kauphusman, Mytty,
`
`and Welch will provide useful, favorable testimony.
`
`Unlike the witnesses that Patent Owner offers, Kauphusman, Mytty, and
`
`Welch led RX engineering efforts and assembled and tested GuideLiner
`
`3
`
`REDACTED
`
`

`

`prototypes. But their laboratory notebooks reveal that at most, they performed only
`
`OTW work during the relevant period. Thus, Petitioner has evidence tending to
`
`show beyond speculation that Kauphusman, Mytty, and Welch will testify they did
`
`not build or test RX prototypes during the relevant period. That testimony will
`
`undermine Patent Owner’s reduction-to-practice narrative and support Petitioner’s
`
`contention that VSI did not perform critical prototype work sufficient to swear
`
`behind Itou.
`
`VSI engineering documents, declarations, and deposition testimony confirm
`
`that Kauphusman led VSI’s RX engineering and prototype work. Inventor Gregg
`
`Sutton testified that Kauphusman was “the primary engineer working on the rapid
`
`exchange version” in 2005. Ex-1757, 33:11-15; see also Ex-1794, 47:23-48:8
`
`(Sutton identifying Kauphusman as “
`
`
`
`
`
`. Sutton could not remember specifics, but he was “sure” that he met
`
`with Kauphusman “to discuss development of the GuideLiner rapid exchange
`
`device.” Ex-1757, 34:7-20. Sutton and Kauphusman discussed “problem areas”—
`
`including “making the—what we called at the time the backbone”—and other
`
`engineering issues, including “what materials to use, where to get them, how to
`
`make them, [and] how to design them.” Id., 34:21-35:15. Kauphusman—and only
`
`Kauphusman, as far as Petitioner can tell—led RX engineering efforts during the
`
`4
`
`REDACTED
`
`

`

`relevant period. See also id., 36:3-8, 71:25-72:14. Indeed, Kauphusman’s name
`
`appears on the component parts engineering drawings that Patent Owner cites to
`
`argue that VSI assembled RX prototypes in mid-2005. See Ex-2122 ¶¶ 14-18
`
`(citing Ex-2089, Ex-2092, Ex-2113, and Ex-2114 and explaining that Kauphusman
`
`drew the engineering drawings for the parts orders).
`
`Kauphusman led critical engineering and prototype work, but the evidence
`
`more than suggests that Kauphusman did not perform that work during the
`
`relevant period. Kauphusman’s laboratory notebook shows that he worked on only
`
`OTW prototypes in 2005 and 2006. Ex-1760, 86-87, 91-93 (300-centimeter, 0.014”
`
`guidewire indicating OTW, not RX, prototype). And a VSI “Special Work Order
`
`Number Assignment Log” shows that in December 2005, VSI cancelled and could
`
`not complete GuideLiner design verification testing, due to a
`
`
`
`Ex-1768, 14. “Jim K.”—Kauphusman—requested that work and then cancelled it.
`
`This evidence more than suggests that he will have information regarding why VSI
`
`could not complete that work.
`
`Mytty worked alongside Kauphusman and should provide similar testimony.
`
`Sutton identified Mytty as one of the “main individuals working with Mr.
`
`Kauphusman on the RX version.” Ex-1757, 33:23-34:6. Yet Mytty’s two
`
`laboratory notebooks indicate that she worked on only OTW prototypes in 2005
`
`and 2006. Ex-1761, 107-13; Ex-1774, 10-12. Therefore, Petitioner possesses
`
`5
`
`REDACTED
`
`

`

`evidence that tends to show beyond speculation that Mytty will provide useful,
`
`favorable testimony: that VSI did not complete critical RX prototype work or
`
`reduce its inventions to practice when its less-knowledgeable witnesses claim.
`
`Patent Owner contends that Welch built and tested relevant prototypes, too.
`
`See Ex-2118 ¶ 15 (Root declaration stating, “I recall Mr. Sutton and Mr. Welch
`
`(another of the named inventors) leading the efforts to make the first [RX]
`
`prototype”); Ex-1756, 62:3-63:20 (Erb testifying that Welch “was heavily involved
`
`in the testing”), 67:20-69:11 (Erb testifying that “it probably would have been Jeff
`
`Welch” performing material prototype testing). Yet, like Kauphusman and Mytty,
`
`Welch’s notebook tells a different story:
`
`
`
` Ex-1758, 12-14. Thus, like Kauphusman and Mytty,
`
`Petitioner possesses evidence that tends to show beyond speculation that Welch
`
`will provide useful, favorable testimony: that VSI did not complete critical RX
`
`prototype work or reduce its inventions to practice when its less-knowledgeable
`
`witnesses claim.
`
`To Petitioner’s knowledge, the Board has not had the opportunity to address
`
`additional discovery related to rebutting reduction-to-practice arguments. But the
`
`substantive value of the testimony that Petitioner seeks is not unlike the value of
`
`additional discovery that the Board has allowed. For example, the Board
`
`recognized that evidence “relevant to determining whether [an asserted reference]
`
`6
`
`REDACTED
`
`

`

`qualifies as prior art” is useful. Canon Inc. v. Avigilon Fortress Corp., IPR2019-
`
`00311, 2019 WL 4239623, at *2 (PTAB Sept. 6, 2019). Here, Petitioner’s ability to
`
`rebut Patent Owner’s reduction-to-practice arguments will determine whether Itou
`
`is prior art. Existing evidence more than suggests that Kauphusman, Mytty, and
`
`Welch will testify that they do not remember working on RX prototypes in 2005-
`
`2006 and that, if they had, they would have written it down in their notebooks. That
`
`testimony will help Petitioner argue that Patent Owner cannot swear-behind Itou.
`
`The first Garmin factor weighs in favor of allowing the depositions.
`
`III. Second Garmin factor: Petitioner does not seek any information
`regarding Patent Owner’s litigation positions.
`
`
`
`“Asking for the other party’s litigation positions and the underlying basis for
`
`those positions is not necessary in the interest of justice.” Garmin, Paper 26 at 6.
`
`Petitioner does not seek any information regarding Patent Owner’s litigation
`
`positions. The second Garmin factor weighs in favor of allowing the depositions.
`
`IV. Third Garmin factor: Petitioner cannot otherwise obtain the
`information it seeks, including from witnesses that Patent Owner has
`made available.
`
`
`
`“Information a party can reasonably figure out or assemble without a
`
`discovery request would not be in the interest of justice to have produced by the
`
`other party.” Garmin, Paper 26 at 6. The information that Petitioner seeks is non-
`
`7
`
`REDACTED
`
`

`

`public and in only Kauphusman’s, Mytty’s, and Welch’s possession.2 Indeed,
`
`deposition testimony confirms that the witnesses that Patent Owner has chosen to
`
`make available cannot provide the information. Sutton testified that he did not
`
`keep notes tracking GuideLiner work; he relied on Kauphusman and Mytty to keep
`
`notes, testifying that “[m]ost projects’ specific notes are kept by the engineers’
`
`technicians.” Ex-1757, 35:16-36:2. Root indicated that he “[doesn’t] know
`
`specifically who build all the prototypes,” but “[t]he people working on it were
`
`Gregg Sutton, Jeff Welch, maybe Jim Kauphusman,” with “Steve Erb making
`
`components” and “maybe Katie Mytty doing some of the testing.” Ex-1762, 82:19-
`
`25. Sutton confirmed that he only oversaw and did not perform GuideLiner
`
`prototype work. See, e.g., Ex-1757, 33:6-10 (“I wasn’t involved directly with either
`
`of these [working on OTW or RX], other than oversight and direction . . . .”). Erb’s
`
`role was limited to making early components. So according to Patent Owner’s
`
`witnesses, only Kauphusman, Mytty, and Welch were working on relevant
`
`prototypes. Thus, only they can provide testimony likely to undercut Patent
`
`Owner’s reduction-to-practice narrative. Rather than offer the key VSI witnesses,
`
`Patent Owner offers less-knowledgeable witnesses to corroborate its inventors.
`
`
`2 None of these witnesses currently work for Teleflex. And to Petitioner’s
`
`knowledge, none have worked for VSI / Teleflex for many years.
`
`8
`
`REDACTED
`
`

`

`The third Garmin factor weighs in favor of allowing the depositions.
`
`V. The fourth Garmin factor does not apply and, thus, does not weigh
`against the requested discovery.
`
`The fourth Garmin factor considers instructions that accompany written
`
`
`
`discovery. See, e.g., Garmin, Paper 26 at 14 (considering interrogatory and
`
`document request instructions). Here, Petitioner does not seek leave to serve
`
`written discovery. Petitioner will serve only standard subpoenas for testimony.
`
`Kauphusman, Mytty, and Welch will be responsible for testifying truthfully and
`
`completely based on their personal knowledge. The fourth Garmin factor cannot
`
`weigh against allowing the depositions.
`
`VI. Fifth Garmin factor: The depositions will not be burdensome, and
`Petitioner is willing to limit each deposition to four hours.
`
`Under the fifth Garmin factor, the Board considers “financial burden, burden
`
`
`
`on human resources, and burden on meeting the time schedule of Inter Partes
`
`Review.” Garmin, Paper 26 at 6. “Requests should be sensible and responsibly
`
`tailored according to a genuine need.” Id.
`
`The requested depositions will not be burdensome. As mentioned,
`
`Kauphusman, Mytty, and Welch will be responsible for testifying truthfully and
`
`completely based on their personal knowledge. The depositions will impose no
`
`financial burden on the deponents, as Petitioner will travel to the deponents or
`
`provide for remote depositions. Petitioner anticipates that the Board will have the
`
`9
`
`REDACTED
`
`

`

`opportunity to rule on this motion in time for Petitioner to secure these depositions,
`
`if allowed, before it submits its Reply, thereby meeting the schedule for this
`
`proceeding.
`
`Petitioner seeks targeted information from these witnesses related to a
`
`particular time period and a particular project. Thus, Petitioner does not anticipate
`
`that it will need more than four hours for each of the depositions that it seeks.
`
`Further, if the Board does not believe that all three depositions are in the interests
`
`of justice, Petitioner would rank them in the order of Kauphusman, Mytty, and
`
`then Welch. Petitioner asks that Board grant leave to depose as least Kauphusman,
`
`as the evidence suggests that he will have the most useful information.
`
`The fifth Garmin factor weighs in favor of allowing the depositions.
`
`*
`
`*
`
`*
`
`Each Garmin factor weighs in favor of allowing these narrow depositions or
`
`is neutral. Petitioner requests that the Board grant its motion for additional
`
`discovery.
`
`
`
`Dated: July 1, 2021
`
`Respectfully submitted,
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`
`10
`
`REDACTED
`
`

`

`Minneapolis, MN 55402
`Attorney for Petitioner
`
`
`
`
`
`
`
`11
`
`REDACTED
`
`

`

`CERTIFICATE OF SERVICE
`
`I certify that on July 1, 2021, a copy of PETITIONER’S MOTION FOR
`
`ADDITIONAL DISCOVERY: MOTION FOR LEAVE TO SUBPOENA NON-
`
`PARTY WITNESSES (FILED WITH BOARD AUTHORIZATION) and all
`
`supporting exhibits were served in their entirety by electronic mail on Patent
`
`Owner’s counsel at the following addresses indicated in Patent Owner’s
`
`Mandatory Notices:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`dvandenburgh@carlsoncaspers.com
`
`Dennis C. Bremer, Reg. No. 40,528
`dbremer@carlsoncaspers.com
`
`Joseph W. Winkels
`jwinkels@carlsoncaspers.com
`
`Peter M. Kohlhepp
`pkohlhepp@carlsoncaspers.com
`
`Alexander S. Rinn
`pkohlhepp@carlsoncaspers.com
`
`Megan E. Christner, Reg. No. 78,979
`mchristner@carlsoncaspers.com
`
`Respectfully submitted,
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Attorney for Petitioner
`
`12
`
`
`
`Dated: July 1, 2021
`
`
`
`REDACTED
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket